Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  Label: Morvan syndrome
  ORPHAcode: '83467'
  ORPHApacketId: '83467'
  PURL: http://www.orpha.net/ORDO/Orphanet_83467
  Parents:
  - Parent:
    - Label: Autoimmune neurological channelopathy
      ORPHAcode: '98750'
  - Parent:
    - Label: Inflammatory and autoimmune disease with epilepsy
      ORPHAcode: '166484'
  - Parent:
    - Label: Acquired peripheral movement disorder
      ORPHAcode: '221114'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:5000005
      HPOTerm: Anti-CASPR2
  Prevalences:
  - Prevalence:
      PrevalenceClass: no data
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Case(s)
      PrevalenceType: Cases/families
      Source: 27698847[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET_27698847[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: Limbic encephalitis-neuromyotonia-hyperhidrosis-polyneuropathy syndrome
  - Synonym: Morvan fibrillary chorea
  TextSection:
    Contents: Morvan syndrome is a rare life-threatening acquired neurologic disease
      characterized by neuromyotonia dysautonomia and encephalopathy with severe insomnia.
      Signs involving central (e.g. hallucinations confusion amnesia myoclonus) autonomic
      (e.g. variations in blood pressure hyperhidrosis) and peripheral (e.g. painful
      cramps myokymia) hyperactivity as well as systemic manifestations (such as weight
      loss pruritus fever) are reported. Thymoma is present in some cases.
    TextSectionType: Definition
  copyright: Orphanet (c) 2025
  creationDate: '2025-06-26 11:48:15'
  version: 1.3.42 / 4.1.8 [2025-03-03]
